MK-801-induced expression of Fos protein family members in the rat retrosplenial granular cortex

Journal of Neuroscience Research

Volumn 57, Issue 5, 1999, Pages 719-729

  Zhang, X ^a,b   Fan, X D ^a   Mohapel, P ^a   Yu, P H ^a   Boulton, A A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Fos related antigen; FosB; NMDA receptor; Phencyclidine; Schizophrenia

Indexed keywords

DIZOCILPINE; IMMEDIATE EARLY PROTEIN; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PROTEIN C FOS; PSYCHEDELIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CEREBRAL CORTEX; DIZOCILPINE MALEATE; FEMALE; GENE EXPRESSION REGULATION; GENES, FOS; IMMUNOHISTOCHEMISTRY; KETAMINE; NEURONS; PHENCYCLIDINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033199132     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990901)57:5<719::AID-JNR13>3.0.CO;2-7     Document Type: Article

References (75)

1. Allen RM, Young SJ. 1978. Phencyclidine-induced psychosis. Am J Psychiatry 135:1081-1084.
2. Bachus SE, Kleinman JE. 1996. The neuropathology of schizophrenia. J Clin Psychiatr 57(Suppl 11):72-83.
3. Bogerts B. 1993. Recent advances in the neuropathology of schizophrenia. Schiz Bull 19:401-445.
4. Carlin AS, Grant I, Adams KM, Reed R. 1979. Is phencyclidine (PCP) abuse associated with organic mental impairment? Am J Drug Alcohol Abuse 6:273-281.
5. Cirelli C, Pompeiano M, Arrighi P, Tononi G. 1995. Sleep-waking changes after c-fos antisense injection in the medial preoptic area. Neuroreport 6:801-805.
6. Cohen DR, Curran T. 1988. fra-1: a serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol Cell Biol 8:2063-2069.
7. Cohen DR, Curran T. 1989. The structure and function of the fos proto-oncogene. Crit Rev Oncogene 1:65-88.
8. Cosgrove J, Newell TG. 1991. Recovery of neuropsychological functions during reduction in use of phencyclidine. J Clin Psychol 47:159-169.
9. Coyle JT. 1996. The glutamatergic dysfunction hypothesis for schizophrenia. Harvard Rev Psychiatry 3:241-253.
10. Curran T, Gordon MB, Rubino KR, Sambucetti LC. 1987. Isolation and characterization of the c-fos (rat) cDNA and analysis of post-translational modification in vitro. Oncogene 2:79-84.
11. Curran T, Miller AD, Zokas L, Verma IM. 1984. Viral and cellular Fos proteins: a comparative analysis. Cell 36:259-268.
12. Doucet JP, Murphy BJ, Tuna BS. 1990. Modification of a discontinuous and highly porous sodium dodecyl sulfate-polyacrylamide gel system for minigel electrophoresis. Anal Biochem 190:209-211.
13. Doucet JP, Nakabeppu Y, Bedard PJ, Hope BT, Nestler EJ, Jasmin BJ, Chen JS, Iadarola MJ, St-Jean M, Wigle N, Blanchet P, Grondin R, Roberson GS. 1996. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of (FosB-like protein(s) in both the rodent and primate striatum. Eur J Neurosci 8:365-381.
14. Duncan GE, Moy SS, Knapp DJ, Mueller RA, Breese GR. 1998. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Res 787:181-190.
15. Gallo M, Bielavska E, Roldan G, Bures J. 1998. Tetrodotoxin inactivation of the gustatory cortex disrupts the effect of the N-methyl-D-aspartate antagonist ketamine on latent inhibition of conditioned taste aversion in rats. Neurosci Lett 240:61-64.
16. Gao XM, Hashimoto T, Tamminga CA. 1998. Phencyclidine (PCP) and dizocilpine (MK801) exert time-dependent effects on the expression of immediate early genes in rat brain. Synapse 29:14-28.
17. Gass P, Herdegen T, Bravo R, Kiessling M. 1993a. Induction and suppression of immediate-early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 53:749-758.
18. Gass P, Herdegen T, Bravo R, Kiessling M. 1993b. Spatiotemporal induction of immediate early genes in rat brain after limbic seizures: effects of NMDA receptor antagonist MK-801. Eur J Neurosci 53:749-758.
19. Goff DC, Wine L. 1997. Glutamate in schizophrenia: clinical and research implications. Schizophr Res 27:157-168.
20. Halberstadt AL. 1995. The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249.
21. Heilig M, Engel JA, Soderpalm B. 1993. C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur J Pharmacol 236:339-340.
22. HerescoLevy U, Javitt DC. 1998. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol 8:141-152.
23. Hiroi N, Brown JR, Haile CN, Ye H, Greenberg ME, Nestler EJ. 1997. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci USA 94:10397-10402.
24. Hiroi N, Marek GJ, Brown JR, Ye H, Saudou F, Vaidya VA, Duman RS, Greenberg ME, Nestler EJ. 1998. Essential role of the FosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J Neurosci 18:6952-6962.
25. Hirsch SR, Das I, Garey LJ, De Belleroche J. 1997. A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav 56:797-802.
26. Hughes P, Dragunow M, Beilharz E, Lawlor P, Gluckman P. 1993. MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurons. Neuroreport 4:183-186.
27. Javitt DC, Zukin SR. 1991. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 138:1301-1308.
28. Jentsch JD, Elsworth JD, Taylor JR, Redmond DE, Roth RH. 1998a. Dysregulation of mesoprefrontal dopamine neurons induced by acute and repeated phencyclidine administration in the nonhuman primate: implications for schizophrenia. Adv Pharmacol 42:810-814.
29. Jentsch JD, Taylor JR, Roth RH. 1998b. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsitivity and augments stress-and psychostimulant-induced hyperlocomotion. Neuropsychopharmacol 19:105-113.
30. Koek W, Woods J, Winger G. 1988. MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produced phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245:969-974.
31. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MBJ, Charney DS. 1994. Subanesthetic doses of the non-competitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry 51:199-214.
32. Luby E, Cohen B, Rosenbaum F, Gottlieb J, Kelley R. 1959. Study of a new schizophrenomimetic drug, Sernyl. Arch Neurol Psychiatry 81:363-369.
33. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A. 1996. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacol 14:301-307.
34. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A. 1997. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacol 17:141-150.
35. Mandelzys A, Gruda MA, Bravo R, Morgan JI. 1997. Absence of a persistently elevated 37 kDa Fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J Neurosci 17:5407-5415.
36. Markowska AL, Olton DS, Murray EA, Gaffan D. 1989. A comparative analysis of the role of fornix and cingulate cortex in memory: rats. Exp Brain Res 74:187-201.
37. Matsui M, Tokuhara M, Konuma Y, Nomura N, Ishizaki R. 1990. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 5:249-255.
38. Morgan JI, Curran T. 1991. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci 14:421-451.
39. Murray EA, Davidson M, Gaffan D, Olton DS, Suomi S. 1989. Effects of fornix transaction and cingulate cortical ablation on spatial memory in monkeys. Exp Brain Res 74:173-186.
40. Nakabeppu Y, Nathans D. 1991. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 64:751-759.
41. Nakki R, Sharp FR, Sagar SM, Honkaniemi J. 1996. Effects of phencyclidine on immediate early gene expression in the brain. J Neurosci Res 45:13-27.
42. Nishina H, Sato H, Suzuki T, Sato M, Iba H. 1990. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 87:3619-3623.
43. O'Donnell P, Grace AA. 1998. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schiz Bull 24:267-283.
44. Ogawa S, Okuyama S, Araki H, Nakazato A, Otomo S. 1994. A rat model of phencyclidine psychosis. Life Sci 55:1605-1610.
45. Olney JW, Labruyere J, Price MT. 1989. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362.
46. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. Sydney: Academic.
47. Pearlson GD. 1981. Psychiatric and medical syndromes associated with phencyclidine (PCP) abuse. Johns Hopkins Med J 148: 25-33.
48. Pennypacker KR, Thai L, Hong JS, McMillian MK. 1994. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J Neurosci 14:3998-4006.
49. Pennypacker KR, Hong JS, McMillian MK. 1995. Implications of Fos-related antigens. Trends Pharmacol Sci 16:317-321.
50. Pie Traszek M, Ossowska K. 1998. Chronic treatment with haloperidol diminishes the phencyclidine-induced sensorimotor gating deficit in rats. Naunyn Schmiedebergs Arch Pharmacol 357:466-471.
51. Port RL, Seybold KS. 1995. Hippocampal synaptic plasticity as a biological substrate underlying spisodic psychosis. Biol Psychiatry 37:318-324.
52. Reperant J, Weidner C, Pakhomova A, Desroches AM, Vesseklin N, Lemire M. 1987. A retino-thalamo-hippocampal pathway in the rat. CR Acad Sci 305:601-604.
53. Rosenbaum G, Cohen BD, Luby ED, Gottlieb JS, Yelen D. 1959. Comparison of phencyclidine hydrochloride (Sernyl) with other drugs: simulation of schizophrenic performance with Sernyl, LSD-25, and amobarbital (Amytal) sodium. I. Attention, motor function, and proprioception. Arch Gen Psychiatry 1:651-656.
54. Sams-Dodd F. 1996. Phencyclidine-induced stereotyped behaviour and social isolation in the rat: a possible animal model of schizophrenia. Behav Pharmacol 7:3-23.
55. Sharp FR, Jasper P, Hall J, Noble L, Sagar SM. 1991. MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol 30:801-809.
56. Shu S, Ju G, Fan L. 1988. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci Lett 85:169-171.
57. Sonnenberg JL, Macgregor-Leon PF, Curran T, Morgan JI. 1989. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3:359-365.
58. Taube JS. 1992. Quantitative analysis of head-direction cells recorded in the rat anterior thalamus. Soc Neurosci Abstr 18:708.
59. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
60. Turgeon SM, Auerbach EA, Heller MA. 1998. The delayed effects of phencyclidine (PCP) disrupt latent inhibition in a conditioned taste aversion paradigm. Pharmacol Biochem Behav 60:553-558.
61. Velakoulis D, Pantelis C. 1996. What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Aust N Z J Psychiatr 30:195-209.
62. Watanabe Y, Johnson RS, Butler LS, Binder DK, Spiegelman BM, Papaioannou VE, McNamara JO. 1996. Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy. J Neurosci 16:3827-3836.
63. Wedzony K, Czyrak A. 1996. Competitive and non-competitive NMDA receptor antagonists induce c-Fos expression in the rat anterior cingulate cortex. J Physiol Pharmacol 47:525-533.
64. Wesierska M, Macias-Gonzalez R, Bures J. 1990. Differential effect of ketamine on the reference and working memory versions of the Morris water maze task. Behav Neurosci 104:74-83.
65. Willets J, Balster RL, Leander D. 1990. The behavioral pharmacology of NMDA receptor antagonists. Trends Pharmacol Sci 11:423-428.
66. Wollnik F, Brysch W, Uhlmann E, Gillardon F, Bravo R, Zimmermann M, Schlingensiepen KH, Herdegen T. 1995. Block of c-fos and junB expression by antisense oligonucleotides inhibits light induced phase shifts of the mammalian clock. Eur J Neurosci 7:388-393.
67. Wyss JM, Van Groen T. 1992. Connections between the retrosplenial cortex and the hippocampal formation in the rat: a review. Hippocampus 2:1-12.
68. Yen J, Wisdom RM, Tratner I, Verma IM. 1991. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc Natl Acad Sci USA 88:5077-5081.
69. Young ST, Porrino LT, Iadarola MJ. 1991. Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc Natl Acad Sci USA 88:1291-1195.
70. Young T, Lawson GW, Gacono CB. 1987. Clinical aspects of phencyclidine (PCP). Int J Addict 22:1-15.
71. Zerial M, Toschi L, Ryseck RP, Schuermann M, Muller R, Bravo R. 1989. The product of a novel growth fact activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J 8:805-813.
72. Zhang X, Boulton AA, Yu PH. 1996. Expression of heat shock protein-70 and limbic seizure-induced neuronal death in the rat brain. Eur J Neurosci 8:1432-1440.
73. Zhang X, Gelowitz DL, Lai CT, Boulton AA, Yu PH. 1997a. Gradation of kainic acid-induced rat limbic seizures and expression of hippocampal heat shock protein-70. Eur J Neurosci 9:760-769.
74. Zhang X, Le Gal La Salle G, Ridoux V, Yu PH, Ju G. 1997b. Prevention of kainic acid-induced limbic seizures and Fos expression by GABA-A receptor agonist muscimol. Eur J Neurosci 9:29-40.
75. Zilles K, Wree A. 1995. Cortex: areal and laminar structure. In: Paxinos G, editor. The rat nervous system, 2nd ed. San Diego: Academic Press. p 649-685.